M6P Therapeutics
Business Services · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
20 S Sarah St, Saint Louis, Missouri, 63...Website
www.m6ptherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About M6P Therapeutics
M6P Therapeutics is dedicated to developing next-generation enzyme replacement and gene therapies specifically for lysosomal storage disorders (LSDs). The company utilizes its innovative S1S3 co-expression platform technology to enhance lysosomal targeting and improve treatment efficacy. Their mission focuses on relieving suffering and improving the lives of individuals affected by these rare, life-threatening diseases. M6P Therapeutics aims to address the urgent needs of patients by providing effective therapeutic solutions.Explore more
M6P Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is M6P Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
M6P Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if M6P Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once M6P Therapeutics has new funding data
Product Launch: Get notified when M6P Therapeutics launches new products
Earning: See what the market has to say on M6P Therapeutics recently announced quarterly report
Click to see if M6P Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at M6P Therapeutics
Check out if M6P Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to M6P Therapeutics
Compare insights from companies similar to M6P Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
M6P Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
M6P Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about M6P Therapeutics.
M6P Therapeutics Tech Stack
A closer look at the technologies used by M6P Therapeutics
M6P Therapeutics News & Media
M6P Therapeutics Presents Promising Preclinical Data In Lysosomal Storage Disorders At The 19th Annual WORLDSymposium™ 2023
Results Highlight Potential Utility of Targeting Mannose 6-Phosphate Pathway to Treat Multiple Lysosomal Storage Disorders Results Highlight Potential Utility of Targeting Mannose 6-Phosphate Pathway to Treat Multiple Lysosomal Storage DisordersM6P Therapeutics Presents Novel AAV Gene Therapy Approach for the Treatment of Gaucher Disease at the ESGCT 29th Annual Congress
ST. LOUIS--(BUSINESS WIRE)--M6P Therapeutics announced a poster presentation at the 29th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) 2022.M6P Therapeutics Presents Promising Preclinical Data in Lysosomal Storage Disorders at the 18th Annual WORLDSymposium™ 2022
ST. LOUIS--(BUSINESS WIRE)--M6P Therapeutics announced the presentation of promising preclinical data among lysosomal storage disorders at the 18th Annual WORLDSymposium™.M6P Therapeutics to Participate in Key Event Highlights at WORLDSymposium™ 2022 and Present Preclinical Data Across Multiple Lysosomal Diseases
ST. LOUIS--(BUSINESS WIRE)--M6P Therapeutics announced its participation at WORLDSymposium™ 2022 conference on lysosomal disorders and research, being held from Feb. 7-11, 2022.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding M6P Therapeutics
Sign Up For FreeTo access detailed company insights
M6P Therapeutics is dedicated to developing next-generation enzyme replacement and gene therapies specifically for lysosomal storage disorders (LSDs). The company utilizes its innovative S1S3 co-expression platform technology to enhance lysosomal targeting and improve treatment efficacy. Their mission focuses on relieving suffering and improving th... Read More
